| References |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Recreation and Sports > Golf > Tiger Woods |
|
References - Tiger Woods
In August, Tiger Woods once again hogged the sports pages with his fifth straight victory on the PGA Tour i According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product n the 2006 season as well as seventh overall PGA championship this year. When you think about the fact that ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in so many great golfers have yet to win a single tournament in their entire careers and yet here is Tiger wit lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. h seven titles this year alone, you can easily why they are saying Woods has a chance to be universally rec here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe gnized as the greatest golfer who ever lived before his career is over. With such a blistering pace to his d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro year so far, it's time once again to review the career record of Tiger Woods to get a better feel of how he ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc currently ranks in history. If there is one period in Woods' career that shows his true dominance, it has easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi to start with his victory at the Memorial Tournament in June 1999 when Woods went on to record one of the g nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically eatest sustained periods of excellence in men's golf history as he went on to capture 17 PGA Tour titles in and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ the two calendar years that followed. Overall, he won 32 PGA championships in the next five calendar years ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi an amazing feet that has not been in professional golf in decades. In late 1999, Tiger also began a recor ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a streak of 264 consecutive weeks as the number one golfer in the world, according to Official World Golf Ra dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod nkings. In his career, Woods has been the world's number one for more weeks than anyone. In that time, Wood cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin also won seven out of 11 major championships, beginning with the 1999 PGA Championship all the way to the tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen 002 US Open. Woods broke Tom Morris' record for largest victory margin ever in a major championship, a hall t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel owed record that had stood since 1862. Woods broke it with a 15-shot win in the 2000 US Open at Pebble Beac ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust . Overall, among major championships, Woods has won The Masters four times (1997, 2001, 2002, 2005), the U y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products Open twice (2000, 2002), The Open Championship three times (2000, 2005, 2006) and the PGA Championship thr . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ee championship (1999, 2000, 2006). And here’s a stunning fact,: in each one of his major victories, Woods elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip had the outright lead or a share of the lead after the third round and held on to it all the way to the end tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Some Economic Background on South Western CO Beat Google's Dampening Link Filter with Article PR The Great British Aikido Controversy
|